PMID- 26165073
OWN - NLM
STAT- MEDLINE
DCOM- 20150918
LR  - 20150713
IS  - 0047-1852 (Print)
IS  - 0047-1852 (Linking)
VI  - 73
IP  - 7
DP  - 2015 Jul
TI  - [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of 
      acid-related disease].
PG  - 1159-62
AB  - We summarized proton pump inhibitors(PPI) and histamine H2-receptor antagonist 
      (H2B) with reference to acid-related disease. The both drugs act process of 
      gastric acid secretion in parietal cell of stomach. Inhibition of H2B is 
      reversible, but that of PPI is irreversible, so period of acting in PPI is longer 
      than that in H2B. PPI is more effective than H2B in treatment of acid-related 
      disease. Especially PPI is recommended the first choice in GERD and NSAID ulcer.
FAU - Kawai, Takashi
AU  - Kawai T
FAU - Yagi, Kenji
AU  - Yagi K
FAU - Moriyasu, Fuminori
AU  - Moriyasu F
LA  - jpn
PT  - English Abstract
PT  - Journal Article
PL  - Japan
TA  - Nihon Rinsho
JT  - Nihon rinsho. Japanese journal of clinical medicine
JID - 0420546
RN  - 0 (Histamine H2 Antagonists)
RN  - 0 (Proton Pump Inhibitors)
SB  - IM
MH  - Duodenal Ulcer/drug therapy
MH  - Gastroesophageal Reflux/*drug therapy
MH  - Gastrointestinal Hemorrhage/drug therapy
MH  - Histamine H2 Antagonists/*therapeutic use
MH  - Humans
MH  - Proton Pump Inhibitors/*therapeutic use
MH  - Stomach Ulcer/drug therapy
EDAT- 2015/07/15 06:00
MHDA- 2015/09/19 06:00
CRDT- 2015/07/14 06:00
PHST- 2015/07/14 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2015/09/19 06:00 [medline]
PST - ppublish
SO  - Nihon Rinsho. 2015 Jul;73(7):1159-62.